Fourth

By Laverne J. Tiffany 4 years ago

FDA Type C meeting communications support plans to initiate Phase 2 in Q2 with NM-002

By Laverne J. Tiffany 4 years ago

CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company

By Laverne J. Tiffany 4 years ago

TipRanks 3 Huge Dividend Shares Yielding at Minimum 8% Analysts Say ‘Buy’ Do you like

By Laverne J. Tiffany 4 years ago

MCLEAN, Va.–(BUSINESS WIRE)–Mar 17, 2021– KLDiscovery Inc. (“KLDiscovery” or the “Company”), a leading global provider

By Laverne J. Tiffany 4 years ago

Clinical data and program update planned for lead program zenocutuzumab (“Zeno”) in 2Q 2021 Clinical

By Laverne J. Tiffany 4 years ago

TipRanks Wells Fargo: 2 Persuasive Stocks With More than 70% Upside Possible The analysts at

By Laverne J. Tiffany 4 years ago

– Many worth-driving milestones expected through 2021 – Trappsol® Cyclo™ Niemann Choose Disorder Style C

By Laverne J. Tiffany 4 years ago

Well-positioned to be a long-term supplier of raw material and critical elements to the modern-day

By Laverne J. Tiffany 4 years ago

Interim Phase 1/2 results for cirmtuzumab with ibrutinib in MCL presented at ASH in December

By Laverne J. Tiffany 4 years ago

NEW YORK, March 11, 2021 (GLOBE NEWSWIRE) — Portman Ridge Finance Corporation (Nasdaq: PTMN) (the